Subscribe and get detailed information

BIOPHARMA CONCLAVE 2019

The Indian biotechnology sector is highly innovative and exponential growth momentum. This sector plays a significant role in enhancing India's global profile along with immense contribution to country's growth economy. India is among the top 12 biotech destinations in the world and ranks 3rd in the Asia-Pacific region. India has the 2nd highest number of US Food and Drug Administration (USFDA) approved plants, after the USA and is the largest producer of recombinant Hepatitis B vaccine. With pharmaceutical industry, dwelling on the growth trajectory, the industry is moving its pace in the Biopharma segment. The move towards more transparent and stringent regulatory regime globally, the Biopharma industry is contributing enormously to health care sector.

With the wide patient population and low manufacturing costs, the India remains an attractive destination for the international Biopharma players. Considering the complexity involved in large molecule development it is extremely crucial to ensure right research and development support, quality assurance and control concerns, fostering innovation environment, developing cutting-edge cost effective products along correct marketing and launch strategies for the lucrative global market.

Considering all these factors, CPhI Conferences is pleased to launch the premier edition of Biopharma Conclave 2019 scheduled on 26th-27th September at The St. Regis, Mumbai. This 2-day comprehensive summit will deliberate on varied aspects such as on Biologics, Gene Therapy, Vaccines, Biosimilars, Biomanufacturing, Intellectual Property Rights, Commercialization and Marketing Strategies in biopharma domain. The objective of this conclave is to enlighten the biopharma professionals with latest trends, address the key challenges and enhance their skills to launch quality drugs in the global market. With case studies, innovation showcases and interactive panel discussions, utilize this exciting opportunity to meet and hear from the movers and shakers in the industry.

STEERING COMMITTEE MEMBERS & SPEAKERS

KEY OBJECTIVES

Better understanding of global and Indian regulatory guidelines along with global harmonization of drug approval

To address the key challenges like patents, manufacturing issues, clinical trials and approvals

Discuss the various solutions around the tedious process and price reduction mechanism

Deliberate on crucial and the most relevant topics to enlighten the bio-pharma professionals in this domain

Live case studies, innovation showcases and interactive panel discussions from the movers and shakers in the industry to deal with our key hassles

Encourage Innovation to launch newer Biologics and tackling problems right from research and development to manufacturing phase

WHY ATTEND

All Biopharma segments covered under one roof
Case studies and practical sessions on different aspects of Biopharma
Enhancing your skills for faster approval of drugs to accelerate the launch
Early entry into markets through faster approvals in the regulated and emerging markets
Understanding best practices in manufacturing and commercialization in accordance to the Indian and global guidelines
Regulators - WHO, FDA, Medicines for Europe, MHRA

TOP 5 REASONS TO PARTNER

RECENT MARKET UPDATES
MEET NEW BUYERS
NETWORKING WITH KEY DECISION MAKERS
DELIVER A TECHNICAL SESSION
SHOWCASE YOUR SOLUTIONS

EVENT PARTNERS

Platinum Partner

Gold Partners

Silver Partners

Exhibit Partners

Media Partners